THE CODI Co.,LTD. (KOSDAQ:224060)

Market Cap	23.84B +46.5%
Revenue (ttm)	25.27B -6.9%
Net Income	24.29B +57.1%
EPS	4,731.31 +45.6%
Shares Out	5.13M
PE Ratio	0.74
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	30,387
Open	5,000.00
Previous Close	5,000.00
Day's Range	4,485.00 - 5,000.00
52-Week Range	2,400.00 - 7,470.00
Beta	-0.09
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 27, 2026

About THE CODI Co.,LTD.

THE CODI Co.,LTD. manufactures and sells semiconductor and display equipment, exposure equipment, and bio-healthcare products. It develops therapeutic agents for various diseases, such as Zika/MERS, glaucoma, non-alcoholic fatty liver, and chronic kidney diseases, as well as immunotherapy to treat cancer and inflammatory diseases. THE CODI Co.,LTD. was formerly known as CODI-M Co., LTD. and changed its name to THE CODI Co.,LTD. in November 2022. THE CODI Co.,LTD. was incorporated in 1999 and is based in Cheonan-si, South Korea.

• Industry: Special Industry Machinery, not elsewhere classified
• Founded: 1999
• Employees: 39
• Stock Exchange: KOSDAQ
• Ticker Symbol: 224060

Financial Performance

In 2025, THE CODI Co.,LTD.'s revenue was 25.27 billion, a decrease of -6.88% compared to the previous year's 27.13 billion. Earnings were 24.29 billion, an increase of 57.06%.